PRACTICE Guidelines REGISTRATION PLATFORM
News MORE
  • 2023.0306

    The Development of Reporting Guideline of clinical Practice Guidelines in General Practice provides detailed guidance for the makers and writers of the general practice guidelines, which will further improve the reporting quality of the general practice guidelines, especially the Chinese general practice guidelines, and promote the application in general medical practice, thus finally improving the quality of primary medical care.

  • 2023.0220

    Professor Gordon Guyatt of McMaster University and Professor Victor Montori of the Mayo Clinic jointly published a paper in the British Medical Journal (BMJ) entitled: Guidelines should consider clinicians' time needed to treat on January 3, 2023.

  • 2022.1126

    IGEST is a generic tool for screening guidelines for any specialty, target population, and healthcare organization, but it is intended only as a screening tool, primarily for quickly assessing guideline quality and determining whether they can be adopted or adapted in other settings, and is not a substitute for some of the more complex guideline quality evaluation tools.

  • 2022.1031

    In July 2022, Jose F. Meneses-Echavez et al. from the Norwegian Institute of Public Health published an article in the Journal of Clinical Epidemiology entitled "Evidence to decision frameworks enabled structured and explicit development of healthcare recommendations". The aim of this study was to identify and describe the processes suggested for the formulation of healthcare recommendations in healthcare guidelines available in guidance documents.

Register MORE
  • 2024.0414
    Migraine is a highly disabling neurological disorder that affects over 1 billion people globally. Migraines are characterized by severe pain and may be accompanied by symptoms such as nausea, vomiting, photophobia and phonophobia, significantly impacting work and daily life. Current treatment methods include acute treatment and preventive treatment. The goal of acute treatment is to rapidly and sustainably alleviate pain and migraine-related symptoms, which is particularly important for improving the quality of life. However, excessive use of acute treatments or addictive acute treatment medications may lead to medication overuse headache, further contributing to chronic and refractory headaches. Additionally, there is currently a lack of standardized acute treatment guidelines for specific patient populations in China. In recent years, with the continuous development of new medications and the emergence of neurostimulation therapies, novel acute treatment approaches for migraines have emerged. Therefore, Chinese Medical Doctor Association and Chinese Research Hospital Association jointly initiated the development of these guidelines for acute migraine treatment, aiming to provide a basis for standardizing migraine treatment.
  • 2024.0412
    For the treatment of infertility patients and fertility protection, there is no universally recognized unified diagnostic standard at home and abroad, and the choice of treatment plan is not the same. The treatment of infertility by traditional Chinese medicine has attracted more and more attention in the process of assisted reproductive technology. Combined with the clinical practice and specific conditions in China, this consensus was compiled to improve the clinician's understanding of the diagnosis and treatment of in vitro fertilization embryo transfer with traditional Chinese and western medicine, so as to achieve the purpose of standardized diagnosis and treatment.
Registration process and operational mode of a CPG registry